Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Retension Pharmaceuticals. Inc.

Clinical trials sponsored by Retension Pharmaceuticals. Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New pill could tame stubborn high blood pressure Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Completed 2

New pill could tame stubborn high blood pressure

Disease control Recruiting now

This study tests a new drug called RTN-001 in adults whose high blood pressure is not controlled by at least two other medications. About 280 participants will take either RTN-001 or a placebo daily for 12 weeks. The main goal is to see if RTN-001 lowers blood pressure more than …

Phase 2 • Sponsor: Retension Pharmaceuticals. Inc. • Aim: Disease control

Last updated Sep 12, 2026 00:00 UTC